Glenmark Pharma gets ANDA approval for Arformoterol Tartrate Inhalation Solution


Glenmark Pharmaceuticals has received final approval by the United States Food & Drug Administration (USFDA) for Arformoterol Tartrate Inhalation Solution, 15 mcg/2 mL, Unit-Dose Vials, the generic version of BROVANA Inhalation Solution, 15 mcg/2 mL, of Sunovion Pharmaceuticals Inc.

Glenmark Pharma was quoting at Rs 641, up Rs 0.30, or 0.05 percent on the BSE.

News Source:- MOneycontrol

For Enquiry Fill The Form

    *Note:- Please provide a valid Email Id to receive OTP from

    Facebook Iconfacebook like buttonYouTube IconTwitter Icontwitter follow button